{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-059806","form_type":"8-K","ticker":"UNCY","cik":"0001766140","company_name":"Unicycive Therapeutics, Inc.","filed_at":"2023-07-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.159612+00:00","generated_at":"2026-06-13T02:24:52.716927+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Unicycive regains Nasdaq minimum market value compliance","bullets":["Received non-compliance notice on May 17, 2023 for MVLS below $35M.","MVLS remained above $35M for 10 consecutive business days ending July 24.","Nasdaq confirmed compliance on July 25, 2023.","Delisting risk removed; stock continues trading on Nasdaq Capital Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-059806","json":"https://secwatch.observer/filing/0001213900-23-059806.json","markdown":"https://secwatch.observer/filing/0001213900-23-059806.md","text":"https://secwatch.observer/filing/0001213900-23-059806.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1766140/000121390023059806/0001213900-23-059806-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1766140/000121390023059806/ea182337-8k_unicycive.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T02:24:52.716927+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}